In addition, VAI has been demonstrated to predict insulin resistance (38) and may be a better surrogate of insulin sensitivity evaluation, in patients with T1D, than insulin requirement, which is influenced by residual pancreatic function and by variability in absorption of insulin in subcutaneous adipose tissue (39). The gene discussed is INS; the disease is Insulin resistance.